A novel series of substituted N,N′-diaryl ureas that act as p38α inhibitors have been designed and synthesized based on two key residues (Gly110 and Thr106) that are different in p38α MAPK than in other kinases. Preliminary biological evaluation indicated that most compounds possessed good p38α inhibitory potencies. Among these compounds, 9g appeared to be the most powerful and is the main compound that we will study in the future.
基于p38α
MAPK与其他激酶相比具有两个关键残基(Gly110和Thr106)差异,设计并合成了一系列作为p38α
抑制剂的替代N,N′-二芳基
脲类化合物。初步
生物学评估表明,大多数化合物具有良好的p38α抑制活性。在这些化合物中,9g似乎是最强大的,并且是我们未来研究的主要化合物。